Product Information
BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.2072 per EA under NDC 70954041430. Its NADAC has been published 213 times since Jun 1, 2022.
The High Outlier badge above means this manufacturer's average price in the Bisoprolol Fumarate and Hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB
Bisoprolol Fumarate and HydrochlorothiazideStrength
10; 6.25 mg/1; mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954041430
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215562On Market Since
11/4/2021
Pharmacological Classes
Price Statistics
The NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB has been published 213 times since Jun 1, 2022, and over the history we have for it it has declined 37.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2072 per EA |
|---|---|
| All-time high | $0.3489 (Nov 16, 2022) |
| All-time low | $0.1227 (Nov 20, 2024) |
| 52-week high | $0.2242 |
| 52-week low | $0.2038 |
| Median price | $0.2409 |
| Average price | $0.2465 |
| Largest weekly change | +49.9% (Dec 18, 2024) |
| Weeks tracked | 213 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB, manufactured by ANI Pharmaceuticals, Inc., is $0.2072 per EA (NDC 70954041430), effective Jun 24, 2026.
How has the price of BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB changed over time?
Over the history we have for it, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB has declined 37.0%. It has been tracked across 213 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?
Since Jun 1, 2022, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB has ranged from a low of $0.1227 (Nov 20, 2024) to a high of $0.3489 (Nov 16, 2022), with a median of $0.2409 per EA.
Are there cheaper alternatives to BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?
3 NADAC-published products share the same active ingredient, strength, and dosage form as BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB, but none are currently priced below it.
Who manufactures BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?
BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB (NDC 70954041430) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification